Arcturus Therapeutics (NASDAQ:ARCT) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Arcturus Therapeutics beat estimated earnings by 68.0%, reporting an EPS of $-0.32 versus an estimate of $-0.99.
Revenue was down $126.30 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.08 which was followed by a 16.0% increase in the share price the next day.
Here's a look at Arcturus Therapeutics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.69 | -0.21 | 0.06 | 0.98 |
EPS Actual | -0.61 | -1.98 | 0.62 | 4.33 |
Revenue Estimate | 15.86M | 48.50M | 37.94M | 72.68M |
Revenue Actual | 45.14M | 10.52M | 80.28M | 160.29M |
To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.